Here, traditional Chinese medicine could be another useful treatment method for PE. Erigeron breviscapus is a native plant species in Yunnan, China. Breviscapine (Bre) is a purified flavonoid extract from this species. Bre has a broad range of pharmacologic effects, including dilation of micro-blood vessels, reduction in blood viscosity and improvement of the micro-circulation. Bre also has an antiplatelet, anti-thrombotic action and can decrease plasma fibrin content and promote fibrinolytic activity. [5] [6] [7] In this study, we evaluated the effect of Bre on PE rat model and analysed the potential mechanism with MCP-1 and IL-13, which provided a research foundation and theoretical basis for the clinical application of Bre.
Firstly, we constructed model animals. The acute pulmonary embolism (APE) models were constructed with two different kinds of embol (DVT and polystyrene (PS) microspheres respectively) through the same surgical procedure, according to Watts. 8 And 40 experiment male SD rats (10 weeks old) were involved. After construction of the APE model with DVT and PS, the symptoms were consistent with the clinical manifestations of cardiopulmonary disease, including shortness of breath and diffuse moist rales. Finding of physiological indicators were on the experiment rats.
0.5 ml of abdominal aortic blood (AAB) and 0.5 ml of peripheral venous blood (PVB) were collected 48 h after drug. Compared with the sham group, the peripheral blood pressure decreased, but the respiratory and heart rates increased significantly in the APE model animals ( Table 1 ). The arterial oxygen tension (PaO 2 ) was significantly lower and the alveolar-arterial difference in carbon dioxide tension (PCO 2 ) was significantly higher in the APE subgroup than in the sham subgroup (P < 0.01).
So, the treatment effect of Bre (i.p.) at a dosage of 1 mg/kg/day was remarkable. There was a dose-dependent effect about Bre intervention. Bre-low and LMWH almost had the same effect (P > 0.05).
Bre could maintain normal blood pressure and heart rate, and improve animal oxygen saturation, which was useful for the improvement of PE symptoms.
At the same time, the D-dimer concentration was determined by a blood test to help diagnose thrombosis. The D-dimer was at the lowest concentration in the sham group than the other four groups. The blood clot was degraded by fibrinolysis, which was also promoted by LMWV. Bre could help the APE rats degrade the blood clot, caused by PS or DVT, which was more apparent at the high dose. Thus, Bre has anti-coagulation activity. Blood clots with PS are difficult to degrade compared to DVT. The D-dimer concentration was lower in these rats.
White blood cell counting in bronchoalveolar alveolar lavage fluid (BALF) was performed for all experimental rats. Compared with the sham group, the total number of white blood cells increased significantly in the model group. After drug intervention, the number of white blood cells began to decline in the Bre injection group, but not the LMWH group. If total white blood cells were classified, the lymphocytes and macrophages were effector 
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